Vimarsana
Biggest News Aggregation in the World

Page 22 - Query Get News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Query Get. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Query Get Today - Breaking & Trending Today

CAR-T shows 'remarkable' efficacy as first-line therapy for large B-cell lymphoma - Vimarsana News

CAR-T shows 'remarkable' efficacy as first-line therapy for large B-cell lymphoma

First-line therapy with axicabtagene ciloleucel induced objective responses in 89% of patients with high-risk large B-cell lymphoma, according to phase 2 study results.An estimated 91% of patients treated with a single infusion of the chimeric antigen receptor T-cell therapy remained alive at 12 months, a primary analysis of the ZUMA-12 trial showed.

Source: healio.com
Top in endocrinology: Diabetic neuropathy; thyroiditis management - Vimarsana News

Top in endocrinology: Diabetic neuropathy; thyroiditis management

Adults with diabetes and neuropathy experience significantly more fatigue than those with diabetes and no neuropathy and people without diabetes, according to a speaker at the American Association of Clinical Endocrinology annual meeting.

Source: healio.com
Study characterizes food protein-induced enterocolitis syndrome in adults - Vimarsana News

Study characterizes food protein-induced enterocolitis syndrome in adults

Adults and children have different experiences with food protein-induced enterocolitis syndrome, although more research is necessary, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice. Specifically, unlike what has been document in the pediatric population, the adult cohort less frequently experienced vomiting, severe acute episodes and development of

Source: healio.com
Study dispels misconceptions of anti-reflux surgery with proof of symptom resolution - Vimarsana News

Study dispels misconceptions of anti-reflux surgery with proof of symptom resolution

SAN DIEGO — Patients who underwent laparoscopic anti-reflux surgery for gastroesophageal reflux disease experienced long-term improvement in symptoms commonly misperceived to persist, according to study results. “Our take home-message is to make patients as well as our colleagues — not only the surgeons but also the primary care physicians and gastroenterologists — who

Source: healio.com
Ustekinumab biosimilar candidate achieves 'therapeutic equivalence' - Vimarsana News

Ustekinumab biosimilar candidate achieves 'therapeutic equivalence'

AVT04, a biosimilar candidate to ustekinumab developed by Alvotech, met the primary endpoint in a confirmatory clinical study of patients with chronic plaque-type psoriasis, according to a company press.

Source: healio.com